Upper Limit of Radiation Treatment Portals in Rectal Cancer: is It Wise to Keep Using Bony Landmarks in the Present Era of 3D Conformal Treatment?

Overview

Journal Rep Pract Oncol Radiother

Specialty Oncology

Date 2023 Oct 5

PMID 37795231

Authors

Surya Prakash Vankina

Surekha Goyal

Geeta S Narayanan

Affiliations

Soon will be listed here.

Abstract

Background: This study aimed to compare the levels of L5-S1 interspace and the bifurcation of common iliac vessels on simulation images of rectal cancer patients to evaluate the adequacy of superior borders in conventional 2D planning for covering internal iliac vessels.

Materials And Methods: Simulation images of 236 rectal cancer patients who received neoadjuvant chemoradiation and surgery were analyzed. The images were retrieved from the radiation treatment database and included delineations of L5-S1 interspace and common iliac vessel bifurcation. Distances between these landmarks were measured.

Results: Among the 236 patients, the majority had the common iliac artery bifurcation positioned above the L5-S1 interspace. Specifically, 78.3% of patients had the right common iliac bifurcation above L5-S1 interspace, with an average distance of 2.02 cm. For the left common iliac artery, 77.11% of patients had the bifurcation above L5-S1 interspace, with an average distance of 1.99 cm. Notably, there were cases where the bifurcations were not at the same level.

Conclusion: Using the L5-S1 junction as the upper border of the treatment portal may result in missing proximal nodes at risk of metastases. However, further research is needed to determine the significance of failures above the L5-S1 interspace for justifying the inclusion of the common iliac artery bifurcation in the treatment portal.

References

Pettersson D, Cedermark B, Holm T, Radu C, Pahlman L, Glimelius B . Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg. 2010; 97(4):580-7. DOI: 10.1002/bjs.6914. View

Martling A, Holm T, Johansson H, Rutqvist L, Cedermark B . The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer. 2001; 92(4):896-902. DOI: 10.1002/1097-0142(20010815)92:4<896::aid-cncr1398>3.0.co;2-r. View

Goldberg P, Nicholls R, Porter N, Love S, Grimsey J . Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: reduction in local treatment failure. Eur J Cancer. 1994; 30A(11):1602-6. DOI: 10.1016/0959-8049(94)00312-s. View

Myerson R, Garofalo M, El Naqa I, Abrams R, Apte A, Bosch W . Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys. 2009; 74(3):824-30. PMC: 2709288. DOI: 10.1016/j.ijrobp.2008.08.070. View

Nilsson P, van Etten B, Hospers G, Pahlman L, van de Velde C, Beets-Tan R . Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial. BMC Cancer. 2013; 13:279. PMC: 3680047. DOI: 10.1186/1471-2407-13-279. View

Bosset J, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A . Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results--EORTC 22921. J Clin Oncol. 2005; 23(24):5620-7. DOI: 10.1200/JCO.2005.02.113. View

Yu T, Bhosale P, Crane C, Iyer R, Skibber J, Rodriguez-Bigas M . Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys. 2008; 71(4):1175-80. PMC: 6455925. DOI: 10.1016/j.ijrobp.2007.11.018. View

Leibold T, Shia J, Ruo L, Minsky B, Akhurst T, Gollub M . Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy. J Clin Oncol. 2008; 26(13):2106-11. DOI: 10.1200/JCO.2007.12.7704. View

Kusters M, Marijnen C, van de Velde C, Rutten H, Lahaye M, Kim J . Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol. 2010; 36(5):470-6. DOI: 10.1016/j.ejso.2009.11.011. View

10.

Pahlman L, Glimelius B . Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg. 1990; 211(2):187-95. PMC: 1357963. DOI: 10.1097/00000658-199002000-00011. View

11.

. Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Swedish Rectal Cancer Trial. Br J Surg. 1993; 80(10):1333-6. DOI: 10.1002/bjs.1800801040. View

12.

Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View

13.

McCall J, Cox M, Wattchow D . Analysis of local recurrence rates after surgery alone for rectal cancer. Int J Colorectal Dis. 1995; 10(3):126-32. DOI: 10.1007/BF00298532. View

14.

Sebag-Montefiore D, Stephens R, Steele R, Monson J, Grieve R, Khanna S . Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009; 373(9666):811-20. PMC: 2668947. DOI: 10.1016/S0140-6736(09)60484-0. View

15.

Ngan S, Burmeister B, Fisher R, Solomon M, Goldstein D, Joseph D . Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol. 2012; 30(31):3827-33. DOI: 10.1200/JCO.2012.42.9597. View

16.

Benson A, Venook A, Al-Hawary M, Arain M, Chen Y, Ciombor K . NCCN Guidelines Insights: Rectal Cancer, Version 6.2020. J Natl Compr Canc Netw. 2020; 18(7):806-815. DOI: 10.6004/jnccn.2020.0032. View

17.

Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C . Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012; 30(16):1926-33. DOI: 10.1200/JCO.2011.40.1836. View

18.

Valentini V, Gambacorta M, Barbaro B, Chiloiro G, Coco C, Das P . International consensus guidelines on Clinical Target Volume delineation in rectal cancer. Radiother Oncol. 2016; 120(2):195-201. DOI: 10.1016/j.radonc.2016.07.017. View

19.

. Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Rectal Cancer Study Group. Cancer. 1990; 66(1):49-55. DOI: 10.1002/1097-0142(19900701)66:1<49::aid-cncr2820660111>3.0.co;2-1. View